The company's average rating is Strong Buy from 4 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Stereotaxis market sentiment investors' perception of the future value of Stereotaxis. Let us look at a few aspects of Stereotaxis technical analysis. The company has Profit Margin (PM) of
(39.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of
(46.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.46.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of Stereotaxis. In general, sophisticated investors focus on analyzing Stereotaxis stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build Stereotaxis's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of Stereotaxis's intrinsic value. In addition to deriving basic predictive indicators for Stereotaxis, many experienced traders also check how macroeconomic factors affect Stereotaxis price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of Stereotaxis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Stereotaxis. Your research has to be compared to or analyzed against Stereotaxis' peers to derive any actionable benefits. When done correctly, Stereotaxis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Stereotaxis.
How important is Stereotaxis's Liquidity
Stereotaxis
financial leverage refers to using borrowed capital as a funding source to finance Stereotaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Stereotaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Stereotaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Stereotaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Stereotaxis's total debt and its cash.
Stereotaxis Gross Profit
Stereotaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Stereotaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Stereotaxis Gross Profit growth over the last 10 years. Please check Stereotaxis'
gross profit and other
fundamental indicators for more details.
Closer look at Stereotaxis Semi Deviation
Stereotaxis has current Semi Deviation of 4.6. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.
Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Semi Deviation | = | SQRT(SV) |
| = | 4.6 |
Will Stereotaxis retail investors go crazy after another fall?
The total risk alpha is down to 0.38 as of today.
As of the 9th of August, Stereotaxis has the Coefficient Of Variation of 2929.93,
semi deviation of 4.6, and Risk Adjusted Performance of 0.0522. In relation to
fundamental indicators, the
technical analysis model makes it possible for you to check existing technical drivers of Stereotaxis, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have analyzed and interpolated nineteen
technical drivers for Stereotaxis, which can be compared to its competition. Please validate
Stereotaxis semi deviation,
jensen alpha, as well as the
relationship between the Jensen Alpha and
semi variance to decide if Stereotaxis is priced more or less accurately, providing market reflects its prevalent price of 2.09 per share. Please also confirm Stereotaxis
total risk alpha, which is currently at 0.3837 to double-check the company can sustain itself at a future point.
Our Conclusion on Stereotaxis
While many of the other players within the medical instruments & supplies industry are still a little expensive, even after the recent corrections, Stereotaxis may offer a potential longer-term growth to retail investors. Taking everything into account, as of the 9th of August 2022, our analysis shows that Stereotaxis hyperactively responds to market trends. The enterprise is
undervalued and projects
very high odds of distress for the next 2 years. Our concluding 90 days buy vs. sell advice on the enterprise is
Cautious Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Stereotaxis. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com